At Liv Hospital, specialists emphasize that stem cell therapy isn’t a one-size-fits-all solution. Instead, it is carefully indicated for specific diseases, patient profiles, and treatment ...
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat® KMT2A + MRD Assay and Software to its industry-leading ...
1don MSN
An off-the-shelf immunotherapy for targeting solid tumors: Ready-to-use CAR-NKT cells show promise
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...
Ascentage Pharma will be conducting a multicenter, open-label Phase I study designed to evaluate the safety, tolerability, ...
CHENNAI: IIT Madras on Wednesday released a first-of-its-kind cancer genome database covering paediatric leukaemia, ...
Reports of cancer incidence in young adults, generally defined as those under 50 years of age, have increased in recent years. Many factors impact ca | Cancer ...
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...
For more than a decade, doctors and researchers have announced that a handful of people around the world have been cured of ...
Monash University researchers, in collaboration with Harvard University, have discovered how to permanently "switch off" ...
Join leading experts at the analytica conference, showcasing advancements in analytical chemistry, bioanalytics, and ...
The NHS diagnoses kidney cancer late in almost three quarters of cases. The condition is notoriously hard to detect, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results